Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open Label Clinical Trial of Etanercept for the Treatment of Hidradenitis Suppurativa

NCT00107991 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00107991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open Label Clinical Trial of Etanercept for the Treatment of Hidradenitis Suppurativa
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
November 30, 2008
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa